Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population

ConclusionWe found no difference in the prevalence of recurrentPALB2 mutations between cases and healthy controls. The mutations inPALB2 gene seem not to play a major role in bladder and kidney cancer development in Polish patients.

Source: Hereditary Cancer in Clinical Practice - January 8, 2021 Category: Cancer & Oncology Source Type: research